Trials / Conditions / Infection in Solid Organ Transplant Recipients

Infection in Solid Organ Transplant Recipients

11 registered clinical trials studyying Infection in Solid Organ Transplant Recipients — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients NCT05626530	Tufts Medical Center	Phase 4
Completed	The Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients NCT04637321	Methodist Health System	—
Completed	T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays NCT02382211	Oxford Immunotec	—
Completed	Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients NCT02503982	Rabin Medical Center	Phase 4
Completed	Respiratory Viral Infections in Pediatric Transplantation NCT02260596	Duke University	—
Completed	Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients NCT01833416	Helio Tedesco Silva Junior	—
Completed	Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination NCT01761435	Fundación Pública Andaluza Progreso y Salud	Phase 3
Active Not Recruiting	Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT) NCT01527591	University of California, Los Angeles	N/A
Terminated	"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patient NCT01761201	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	Phase 3
Completed	Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patien NCT01446445	Nuria Lloberas	Phase 4
Completed	Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients NCT01558037	Michael Ison	—